Cipher Pharmaceuticals Inc. (TSE:CPH – Get Free Report) (NASDAQ:CPHR) traded down 13.1% during mid-day trading on Friday . The stock traded as low as C$12.87 and last traded at C$12.88. 102,451 shares changed hands during trading, an increase of 268% from the average session volume of 27,845 shares. The stock had previously closed at C$14.82.
Cipher Pharmaceuticals Stock Performance
The company has a quick ratio of 2.67, a current ratio of 2.00 and a debt-to-equity ratio of 41.22. The firm has a market capitalization of C$342.31 million, a P/E ratio of 29.30 and a beta of 0.89. The company’s 50 day moving average is C$15.35 and its 200-day moving average is C$13.96.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.
Further Reading
- Five stocks we like better than Cipher Pharmaceuticals
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- Investing in Travel Stocks Benefits
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- Roth IRA Calculator: Calculate Your Potential Returns
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
